MedAdvisor Solutions' helps pharmacists in Australia deliver more than 115,000 clinical services to patients through Expanded Scope of Practice Pilots in 2024

January 21, 2025 10:22 AM AEDT | By Cision
Follow us on Google News: https://kalkinemedia.com/resources/assets/public/images/google-news.webp

New case study showcases improved operational efficiency and patient care with enhanced workflow and clinical services for pharmacists

MELBOURNE, Australia, Jan. 21, 2025 /PRNewswire/ -- MedAdvisor Solutions, a global leader in patient engagement and pharmacy technology, published its newest case study revealing the success of Australia's Expanded Scope of Practice initiative across more than 3,800 pharmacies in the country. The MedAdvisor for Pharmacy platform, used by more than 95% of Australian pharmacies, powers the functionality to support the expanded scope of practice, a government initiative designed to address healthcare workforce shortages and long patient wait times, particularly in rural areas. The case study, Australia's Expanded Scope of Practice: Empowering Pharmacists, Transforming Healthcare, explores why the Australian government launched this initiative back in 2020 and how – with MedAdvisor's technology – it has impacted the healthcare system, highlighting the pivotal role pharmacists play in addressing the nation's care challenges.

More than 39% of Australians wait more than four weeks to see a general practitioner due to workforce shortage issues1.This leads to treatment delays for patients and overcrowded emergency departments, much of which can be managed through local pharmacies. To lessen this growing strain on the healthcare system, highly trained pharmacists nationwide are starting to provide services for certain acute conditions, like minor ailments and routine medication management.  MedAdvisor's case study offers a comprehensive look at how the country's Expanded Scope of Practice initiative is empowering pharmacists to provide these vital care services, reducing the burden on general practitioners and emergency departments while improving access for patients.

Key Highlights from the case study Include:

  • Empowered Pharmacists: Expanded roles allow pharmacists to conduct consultations, prescribe medications, administer vaccines, and manage chronic diseases.

  • Technology-Driven Solutions: MedAdvisor's innovative platforms provide the infrastructure for enhanced patient care and seamless collaboration with providers.

  • Real-World Impact: Success stories from Queensland and New South Wales demonstrate how pharmacists have delivered thousands of consultations and improved health outcomes.

  • The Future of Pharmacy: Insights into how technology and AI will further transform pharmacies into primary healthcare destinations.

"Australia's effort to expand pharmacists' scope of practice gives patients more options and pathways to access services, which ultimately improves the healthcare experience," said Carolyn Clementson, prescribing pharmacist at Good Price Pharmacy Warehouse. "Giving pharmacists these new capabilities further their capacity to engage and interact with patients, providing stronger health outcomes and more satisfaction with the care journey."

In 2023, the Australian government chose MedAdvisor Solutions as the preferred software for its Expanded Scope of Practice initiative. In the last 12 months more than 115,000 patients are receiving services through this program across more than 3,800 pharmacies. By streamlining administrative tasks and improving workflow efficiency, the company's MedAdvisor for Pharmacy cloud-based, workflow and clinical services platform allows pharmacists to focus on patient care and take on more of these clinical roles. This collaboration is providing patients, pharmacies, and pharmacists with the needed tech and AI-enabled solutions to drive the future of pharmacy, better outcomes and an improved experience for all.

"Today's case study illustrates how critical pharmacists are to primary care delivery and enhancing access to care in Australia," said Rick Ratliff, CEO of MedAdvisor Solutions. "It showcases how pharmacists, supported by cutting-edge technology, are stepping up to meet the growing demands of our healthcare system. At MedAdvisor, we're committed to empowering pharmacists and pharmacies with tools that not only enhance operational efficiency, but also improve patient outcomes."

MedAdvisor's involvement with this initiative underscores the company's role in supporting pharmacists through real-time clinical data, secure communication systems, and tailored solutions. The multi-faceted approach is pivotal as the industry continues to search for innovative ways to lessen strain on the healthcare system and improve patient access to care.

Additional information

For more detailed information about how prescribing pharmacists see the changes, click here to access our Case Study: Interview with Carolyn Clementson, prescribing pharmacist, Good Price Pharmacy Warehouse

About MedAdvisor Solutions 

MedAdvisor Solutions is a global leader of pharmacy-driven patient engagement solutions that provide individualized patient experiences to simplify the patient medication journey. Our solutions utilise an empathetic, data-driven approach to engagement and an innovative, patient-centric digital experience that empower the pharmacy of the future and inspire lasting behaviour change. MedAdvisor Solutions works with over 37,000 pharmacies across the US, Australia & New Zealand to deliver our solutions to help patients take their medication safely and effectively. 

In Australia, MedAdvisor Solutions has connected nearly 4 million patients through more than 95% of Australian pharmacies. MedAdvisor Solutions is on track to become one of the largest players to aid in the global transformation of the pharmacy of the future through digital patient engagement solutions. In 2018 and 2020, MedAdvisor Solutions was recognized in the AFR Fast 100 and in 2022, 2023 and 2024 received the Retail Excellence Award (REX) for Technology & Automation from Drug Store News. 

www.medadvisorsolutions.com  

1 OECD (2020), Waiting Times for Health Services: Next in Line, OECD Health Policy Studies, OECD Publishing, Paris

Logo - https://mma.prnasia.com/media2/2507736/MedAdvisor_Solutions_Logo.jpg?p=medium600 


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.

Two ASX Listed Stocks Giving Bullish Indications

Recent Articles

Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.